[Chronic hepatitis B and C in renal graft recipients]

Area of Science:

• Hepatology
• Nephrology
• Transplantation Immunology

Context:

• Renal graft recipients are susceptible to chronic viral hepatitis.
• Understanding the distinct clinical and morphological features of hepatitis B (CHB), C (CHC), and co-infection (CHB+C) is crucial in this population.
• This study investigates the comparative disease profiles of CHB, CHC, and CHB+C in 283 renal transplant recipients.

Purpose:

• To compare the clinical and morphological manifestations of chronic hepatitis B, C, and B+C in renal graft recipients.
• To assess differences in liver enzyme activity, bilirubin levels, and histopathological findings.
• To determine the prevalence of advanced liver fibrosis and cirrhosis in relation to hepatitis type.

Summary:

• Higher serum bilirubin and ALT levels were observed more frequently in CHB and CHB+C patients than in CHC patients.
• Histopathological analysis revealed a more severe liver lesion in CHB, with significantly higher rates of advanced fibrosis or cirrhosis compared to CHC.
• While stable low hepatitis activity was common across groups, CHB demonstrated more pronounced inflammatory activity and fibrotic progression.

Impact:

• These findings highlight that chronic hepatitis B presents a more aggressive clinical and morphological picture in renal graft recipients than chronic hepatitis C.
• This underscores the importance of vigilant monitoring and potentially tailored treatment strategies for CHB in immunosuppressed transplant patients.
• The study provides valuable insights for managing viral hepatitis in the context of solid organ transplantation.